At USD 7 billion, global neuromodulation market forecasts are positive according to this new research of 102 pages published in September 2018 and now available with Market Study Report.
North America is the most attractive region in global neuromodulation market while APAC is slated to grow at the highest rate, and China, India and Japan will be major igniters. Chronic pain is the major application segment of the neuromodulation industry says this research discussing companies like Medtronic, Boston Scientific, St. Jude Medical (Abbott), Liva Nova, Nevro and others. These major market players are evaluated on various parameters such as company overview, product portfolios, market revenue and recent development of the neuromodulation market.
By technology, this neuromodulation industry report covers Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS) and Other Technologies. Applications in Chronic Pain, Parkinson’s Disease, Urinary Fecal Incontinence, Refractory Epilepsy, Essential Tremor, Dystonia, Gastroparesis, Treatment Resistant Depression (TRD), Obsessive Compulsive Disorder (OCD) and Other Applications have been covered. Regionally, the research talks about neuromodulation market in North America, Europe, Asia Pacific, Latin America and Rest of the World (ROW).
Order a copy of the Global Neuromodulation Market Research Report 2018 at
https://www.marketstudyreport.com/securecheckout/paymenta/1232920?msfpaycode=sumsf .
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis and information according to categories such as application, technology, geography, company and competitive landscape. A comprehensive analysis has been done on market share of all the categories. Key trends in terms of merger & acquisitions, collaborations, partnerships and agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Neuromodulation market.
With such an extensive therapeutic scope, and immense ongoing enhancements in biotechnology, neuromodulation will likely be a leading growth industry over the forecast period. The growth of the sector is largely stimulated by an increased uptake of neuromodulation devices, surging prevalence of diseases pertaining to neuromodulation, ageing population, technological advances and deal making activity globally.
Table of Contents for this report include:
3.1 Global Neuromodulation Market Share, By Technology
3.2 Global Neuromodulation Market Share, By Region
3.3 Global Neuromodulation Market Share, By Application
3.4 Global Neuromodulation Market Share, By Company
4.1 Market Drivers
4.2 Market Inhibitors
5.1 Spinal Cord Stimulation
5.2 Deep Brain Stimulation
5.3 Sacral Nerve Stimulation
5.4 Vagus Nerve Stimulation
5.5 Other Technologies
6.1 North America
6.2 Europe
6.3 Asia Pacific
6.4 Latin America
6.5 Rest of the World (ROW)
7.1 Chronic Pain
7.2 Parkinson?s Disease
7.3 Urinary Fecal Incontinence (UFI)
7.4 Refractory Epilepsy
7.5 Essential Tremor
7.6 Dystonia
7.7 Gastroparesis
7.8 Treatment Resistant Depression (TRD)
7.9 Obsessive Compulsive Disorder (OCD)
7.10 Other Application
8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships
9.1 Medtronic
9.1.1 Business Overview
9.1.2 Neuromodulation Products Portfolio
9.1.3 Neuromodulation Sales Analysis & Forecast
9.1.4 Recent Development
9.2 Boston Scientific
9.2.1 Business Overview
9.2.2 Neuromodulation Products Portfolio
9.2.3 Neuromodulation Sales Analysis & Forecast
9.2.4 Recent Development
9.3 St Jude Medical (Abbott)
9.3.1 Business Overview
9.3.2 Neuromodulation Products Portfolio
9.3.3 Neuromodulation Sales Analysis & Forecast
9.3.4 Recent Development
9.4 Liva Nova (Cyberonics)
9.4.1 Business Overview
9.4.2 Neuromodulation Products Portfolio
9.4.3 Neuromodulation Sales Analysis & Forecast
9.4.4 Recent Development
9.5 Nevro
9.5.1 Business Overview
9.5.2 Neuromodulation Products Portfolio
9.5.3 Neuromodulation Sales Analysis & Forecast
9.5.4 Recent Development
Order a copy of the Global Neuromodulation Market Research Report 2018 at
https://www.marketstudyreport.com/securecheckout/paymenta/1232920?msfpaycode=sumsf .
Another study titled Global Neuromodulation Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 is of 118 pages and says key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer’s and Parkinson’s diseases, and the increase in awareness regarding the safety and efficacy of neurostimulator devices. However, restrains, such as lack of trained healthcare professionals and stringent approval policies, are expected to hinder the market. Regional and country level coverage of this report includes North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia) as well as Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). Read more at https://www.marketstudyreport.com/reports/global-neuromodulation-market-2018-by-manufacturers-countries-type-and-application-forecast-to-2023 .
About Us:
MarketStudyReport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com